FOXP3 and neoplasm: CD4+ FoxP3+ Tregs, which exert a suppressive effect on effector T cells implicated in tumor surveillance, have been shown to account for a large proportion of tumor-infiltrating lymphocytes (TILs) in melanoma and breast cancer that do not respond to ICI [38].